Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 7 AUD -0.43% Market Closed
Market Cap: 568.8m AUD

Intrinsic Value

The intrinsic value of one MYX stock under the Base Case scenario is 8.22 AUD. Compared to the current market price of 7 AUD, Mayne Pharma Group Ltd is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MYX Intrinsic Value
8.22 AUD
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Mayne Pharma Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MYX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MYX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Mayne Pharma Group Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Mayne Pharma Group Ltd’s research
View All Researches
Mayne Pharma Group Ltd
ASX:MYX
AU
Pharmaceuticals
Market Cap
568.7m AUD
IPO
Jun 29, 2007
AU
Pharmaceuticals
Market Cap
568.7m AUD
IPO
Jun 29, 2007
Price
AU$false
EPS
AU$false
AI Assistant
AI Assistant
Ask me anything about Mayne Pharma Group Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Mayne Pharma Group Ltd

Balance Sheet Decomposition
Mayne Pharma Group Ltd

Current Assets 429.5m
Cash & Short-Term Investments 127.4m
Receivables 211.2m
Other Current Assets 90.9m
Non-Current Assets 701.2m
PP&E 57.5m
Intangibles 580.2m
Other Non-Current Assets 63.6m
Efficiency

Free Cash Flow Analysis
Mayne Pharma Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mayne Pharma Group Ltd

Revenue
419.2m AUD
Cost of Revenue
-169.7m AUD
Gross Profit
249.5m AUD
Operating Expenses
-368.7m AUD
Operating Income
-119.2m AUD
Other Expenses
-10.1m AUD
Net Income
-129.2m AUD
Fundamental Scores

MYX Profitability Score
Profitability Due Diligence

Mayne Pharma Group Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
27/100
Profitability
Score

Mayne Pharma Group Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

MYX Solvency Score
Solvency Due Diligence

Mayne Pharma Group Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
54/100
Solvency
Score

Mayne Pharma Group Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MYX Price Targets Summary
Mayne Pharma Group Ltd

Wall Street analysts forecast MYX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYX is 7.55 AUD with a low forecast of 7.47 AUD and a high forecast of 7.77 AUD.

Lowest
Price Target
7.47 AUD
7% Upside
Average
Price Target
7.55 AUD
8% Upside
Highest
Price Target
7.77 AUD
11% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MYX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MYX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MYX stock?

The intrinsic value of one MYX stock under the Base Case scenario is 8.22 AUD.

Is MYX stock undervalued or overvalued?

Compared to the current market price of 7 AUD, Mayne Pharma Group Ltd is Undervalued by 15%.

Back to Top